These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20036466)

  • 1. Fear potentiation is associated with hypothalamic-pituitary-adrenal axis function in PTSD.
    Jovanovic T; Norrholm SD; Blanding NQ; Phifer JE; Weiss T; Davis M; Duncan E; Bradley B; Ressler K
    Psychoneuroendocrinology; 2010 Jul; 35(6):846-57. PubMed ID: 20036466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone facilitates fear extinction and safety discrimination in PTSD: A placebo-controlled, double-blind study.
    Michopoulos V; Norrholm SD; Stevens JS; Glover EM; Rothbaum BO; Gillespie CF; Schwartz AC; Ressler KJ; Jovanovic T
    Psychoneuroendocrinology; 2017 Sep; 83():65-71. PubMed ID: 28595089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol suppression by dexamethasone reduces exaggerated fear responses in posttraumatic stress disorder.
    Jovanovic T; Phifer JE; Sicking K; Weiss T; Norrholm SD; Bradley B; Ressler KJ
    Psychoneuroendocrinology; 2011 Nov; 36(10):1540-52. PubMed ID: 21601366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
    Rinne T; de Kloet ER; Wouters L; Goekoop JG; DeRijk RH; van den Brink W
    Biol Psychiatry; 2002 Dec; 52(11):1102-12. PubMed ID: 12460693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity.
    Jovanovic T; Norrholm SD; Fennell JE; Keyes M; Fiallos AM; Myers KM; Davis M; Duncan EJ
    Psychiatry Res; 2009 May; 167(1-2):151-60. PubMed ID: 19345420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain.
    Heim C; Ehlert U; Hanker JP; Hellhammer DH
    Psychosom Med; 1998; 60(3):309-18. PubMed ID: 9625218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine response to CRF stimulation in veterans with and without PTSD in consideration of war zone era.
    Golier JA; Caramanica K; Yehuda R
    Psychoneuroendocrinology; 2012 Mar; 37(3):350-7. PubMed ID: 21813244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired fear inhibition is a biomarker of PTSD but not depression.
    Jovanovic T; Norrholm SD; Blanding NQ; Davis M; Duncan E; Bradley B; Ressler KJ
    Depress Anxiety; 2010 Mar; 27(3):244-51. PubMed ID: 20143428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired fear inhibition learning predicts the persistence of symptoms of posttraumatic stress disorder (PTSD).
    Sijbrandij M; Engelhard IM; Lommen MJ; Leer A; Baas JM
    J Psychiatr Res; 2013 Dec; 47(12):1991-7. PubMed ID: 24090716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTSD and the HPA axis: differences in response to the cold pressor task among individuals with child vs. adult trauma.
    Santa Ana EJ; Saladin ME; Back SE; Waldrop AE; Spratt EG; McRae AL; LaRowe SD; Timmerman MA; Upadhyaya H; Brady KT
    Psychoneuroendocrinology; 2006 May; 31(4):501-9. PubMed ID: 16413134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of comorbidity and trauma exposure and its timing in shaping HPA axis patterns in depression.
    Mayer SE; Peckins M; Kuhlman KR; Rajaram N; Lopez-Duran NL; Young EA; Abelson JL
    Psychoneuroendocrinology; 2020 Oct; 120():104776. PubMed ID: 32593866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic activity and hypothalamo-pituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling.
    van Liempt S; Arends J; Cluitmans PJ; Westenberg HG; Kahn RS; Vermetten E
    Psychoneuroendocrinology; 2013 Jan; 38(1):155-65. PubMed ID: 22776420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of BDNF Val66Met, PTSD, and child abuse on psychophysiological reactivity and HPA axis function in a sample of Gulf War Veterans.
    Young DA; Neylan TC; O'Donovan A; Metzler T; Richards A; Ross JA; Inslicht SS
    J Affect Disord; 2018 Aug; 235():52-60. PubMed ID: 29649711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: a meta-analysis.
    Klaassens ER; Giltay EJ; Cuijpers P; van Veen T; Zitman FG
    Psychoneuroendocrinology; 2012 Mar; 37(3):317-31. PubMed ID: 21802212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
    Muhtz C; Wester M; Yassouridis A; Wiedemann K; Kellner M
    J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the hypothalamic-pituitary-adrenal axis over a 24-hour diurnal period and in response to neuroendocrine challenges in women with and without childhood sexual abuse and posttraumatic stress disorder.
    Bremner JD; Vythilingam M; Anderson G; Vermetten E; McGlashan T; Heninger G; Rasmusson A; Southwick SM; Charney DS
    Biol Psychiatry; 2003 Oct; 54(7):710-8. PubMed ID: 14512211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder.
    Inslicht SS; Rao MN; Richards A; O'Donovan A; Gibson CJ; Baum T; Metzler TJ; Neylan TC
    Psychoneuroendocrinology; 2018 Feb; 88():136-143. PubMed ID: 29268182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel AX+/BX- paradigm to assess fear learning and safety-signal processing with repeated-measure designs.
    Kazama AM; Schauder KB; McKinnon M; Bachevalier J; Davis M
    J Neurosci Methods; 2013 Apr; 214(2):177-83. PubMed ID: 23376500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.